Synonyms: VX-853 | VX853
Compound class:
Synthetic organic
Comment: Timcodar (VX-853) is a pyridine compound that was developed by Vertex Pharmaceuticals. It acts as a mammalian and bacterial efflux pump inhibitor. It was proposed to enhance activity of antibacterials such as rifampin, by inhibiting their efflux via bacterial efflux pumps [1,3]. It was also investigated for potential to prevent efflux of chemotherapy drugs, to enhance cancer treatment, and has been proposed as a possible antiobesity therapy [2].
|
|
References |
1. Grossman TH, Shoen CM, Jones SM, Jones PL, Cynamon MH, Locher CP. (2015)
The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents. Antimicrob Agents Chemother, 59 (3): 1534-41. [PMID:25534740] |
2. Hinds Jr TD, John K, McBeth L, Trabbic CJ, Sanchez ER. (2016)
Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses Adipogenesis. PPAR Res, 2016: 6218637. [PMID:27190501] |
3. Mullin S, Mani N, Grossman TH. (2004)
Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853). Antimicrob Agents Chemother, 48 (11): 4171-6. [PMID:15504837] |